• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胸部恶性肿瘤放射技术的进展

Developments in radiation techniques for thoracic malignancies.

作者信息

Finazzi Tobias, Schneiders Famke L, Senan Suresh

机构信息

Clinic of Radiotherapy and Radiation Oncology, University Hospital Basel, Basel, Switzerland

Dept of Radiation Oncology, Amsterdam University Medical Centers, Location VUmc, Amsterdam, The Netherlands.

出版信息

Eur Respir Rev. 2021 May 5;30(160). doi: 10.1183/16000617.0224-2020. Print 2021 Jun 30.

DOI:10.1183/16000617.0224-2020
PMID:33952599
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9488563/
Abstract

Radiation therapy is a cornerstone of modern lung cancer treatment alongside surgery, chemotherapy, immunotherapy and targeted therapies. Advances in radiotherapy techniques have enhanced the accuracy of radiation delivery, which has contributed to the evolution of radiation therapy into a guideline-recommended treatment in both early-stage and locally advanced nonsmall cell lung cancer. Furthermore, although radiotherapy has long been used for palliation of disease in advanced lung cancer, it is increasingly having a role as a locally ablative treatment in patients with oligometastatic disease.This review provides an overview of recent developments in radiation techniques, particularly for non-radiation oncologists who are involved in the care of lung cancer patients. Technical advances are discussed, and findings of recent clinical trials are highlighted, all of which have led to a changing perception of the role of radiation therapy in multidisciplinary care.

摘要

放射治疗是现代肺癌治疗的基石,与手术、化疗、免疫疗法和靶向治疗并驾齐驱。放射治疗技术的进步提高了放射剂量传递的准确性,这促使放射治疗在早期和局部晚期非小细胞肺癌中发展成为指南推荐的治疗方法。此外,尽管放射治疗长期以来一直用于晚期肺癌的姑息治疗,但在寡转移疾病患者中,它作为局部消融治疗的作用越来越大。本综述概述了放射技术的最新进展,特别是为参与肺癌患者护理的非放射肿瘤学家提供参考。文中讨论了技术进步,并强调了近期临床试验的结果,所有这些都导致了人们对放射治疗在多学科治疗中作用的看法发生了变化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2ed/9488563/837ff8d617bf/ERR-0224-2020.04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2ed/9488563/3296c432a6a8/ERR-0224-2020.01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2ed/9488563/5be13a24c44e/ERR-0224-2020.02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2ed/9488563/45d97693c77e/ERR-0224-2020.03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2ed/9488563/837ff8d617bf/ERR-0224-2020.04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2ed/9488563/3296c432a6a8/ERR-0224-2020.01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2ed/9488563/5be13a24c44e/ERR-0224-2020.02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2ed/9488563/45d97693c77e/ERR-0224-2020.03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2ed/9488563/837ff8d617bf/ERR-0224-2020.04.jpg

相似文献

1
Developments in radiation techniques for thoracic malignancies.胸部恶性肿瘤放射技术的进展
Eur Respir Rev. 2021 May 5;30(160). doi: 10.1183/16000617.0224-2020. Print 2021 Jun 30.
2
Treatment of Oligometastatic Non-Small Cell Lung Cancer: An ASTRO/ESTRO Clinical Practice Guideline.寡转移非小细胞肺癌的治疗:美国放射肿瘤学会/欧洲放射肿瘤学会临床实践指南
Pract Radiat Oncol. 2023 Sep-Oct;13(5):393-412. doi: 10.1016/j.prro.2023.04.004. Epub 2023 Apr 25.
3
Radiation Therapy for Thoracic Malignancies.胸部恶性肿瘤放射治疗。
Hematol Oncol Clin North Am. 2020 Feb;34(1):109-125. doi: 10.1016/j.hoc.2019.09.007. Epub 2019 Oct 31.
4
Radiation therapy as a backbone of treatment of locally advanced non-small cell lung cancer.放射治疗作为局部晚期非小细胞肺癌治疗的基础。
Semin Oncol. 2014 Feb;41(1):57-68. doi: 10.1053/j.seminoncol.2013.12.012. Epub 2013 Dec 12.
5
Unresected stage III non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group.未切除的Ⅲ期非小细胞肺癌。省级肺癌疾病部位组。
Cancer Prev Control. 1997 Aug;1(3):249-59.
6
Palliative radiotherapy regimens for patients with thoracic symptoms from non-small cell lung cancer.针对非小细胞肺癌引起胸部症状患者的姑息性放疗方案。
Cochrane Database Syst Rev. 2015 Jan 14;1(1):CD002143. doi: 10.1002/14651858.CD002143.pub4.
7
A critical review of recent developments in radiotherapy for non-small cell lung cancer.对非小细胞肺癌放射治疗近期进展的批判性综述。
Radiat Oncol. 2016 Sep 6;11(1):115. doi: 10.1186/s13014-016-0693-8.
8
Reirradiation of recurrent node-positive non-small cell lung cancer after previous stereotactic radiotherapy for stage I disease : A multi-institutional treatment recommendation.先前接受立体定向放射治疗的 I 期复发性淋巴结阳性非小细胞肺癌再照射:多机构治疗建议。
Strahlenther Onkol. 2017 Jul;193(7):515-524. doi: 10.1007/s00066-017-1130-0. Epub 2017 Apr 19.
9
Proton Therapy in Non-small Cell Lung Cancer.质子治疗非小细胞肺癌。
Curr Treat Options Oncol. 2018 Nov 27;19(12):76. doi: 10.1007/s11864-018-0588-z.
10
Role of immunotherapy in oligometastatic nonsmall cell lung cancer.免疫疗法在寡转移非小细胞肺癌中的作用。
BMJ Case Rep. 2021 May 10;14(5):e241070. doi: 10.1136/bcr-2020-241070.

引用本文的文献

1
Added value of EUS-B-FNA to bronchoscopy and EBUS-TBNA in diagnosing and staging of lung cancer.超声内镜引导下细针穿刺活检术(EUS-B-FNA)在肺癌诊断及分期中相对于支气管镜检查和超声支气管镜引导下经支气管针吸活检术(EBUS-TBNA)的附加价值。
Eur Clin Respir J. 2024 Jun 9;11(1):2362995. doi: 10.1080/20018525.2024.2362995. eCollection 2024.
2
Patients with Lower Positive Lymph Nodes Ratio May Benefit from Preoperative Radiotherapy in Stage III Non-Small Cell Lung Cancer.低阳性淋巴结比例的 III 期非小细胞肺癌患者可能从术前放疗中获益。
Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231173498. doi: 10.1177/15330338231173498.
3
The Preventive Effect of Endostar on Radiation-induced Pulmonary Fibrosis.

本文引用的文献

1
Protocol of the TREASURE study: Thoracic RadiothErapy with Atezolizumab in Small cell lUng canceR Extensive disease - a randomized, open-label, multicenter phase II trial.TREASURE 研究方案:阿替利珠单抗联合胸部放疗治疗广泛期小细胞肺癌——一项随机、开放标签、多中心 II 期试验。
BMC Cancer. 2022 Sep 24;22(1):1011. doi: 10.1186/s12885-022-10074-9.
2
Consolidation nivolumab and ipilimumab versus observation in limited-disease small-cell lung cancer after chemo-radiotherapy - results from the randomised phase II ETOP/IFCT 4-12 STIMULI trial.化疗放疗后局限期小细胞肺癌中纳武利尤单抗与伊匹木单抗巩固治疗对比观察——随机II期ETOP/IFCT 4-12 STIMULI试验结果
Ann Oncol. 2022 Jan;33(1):67-79. doi: 10.1016/j.annonc.2021.09.011. Epub 2021 Sep 23.
3
恩度对放射性肺纤维化的预防作用。
Curr Mol Med. 2024;24(5):610-619. doi: 10.2174/1566524023666230406134640.
4
Health Economic Evaluation of Proton Therapy for Lung Cancer: A Systematic Review.质子治疗肺癌的健康经济学评价:系统评价。
Int J Environ Res Public Health. 2023 Mar 7;20(6):4727. doi: 10.3390/ijerph20064727.
5
The Multidisciplinary Approach in Stage III Non-Small Cell Lung Cancer over Ten Years: From Radiation Therapy Optimisation to Innovative Systemic Treatments.十年来 III 期非小细胞肺癌的多学科治疗方法:从放射治疗优化到创新的全身治疗
Cancers (Basel). 2022 Nov 20;14(22):5700. doi: 10.3390/cancers14225700.
6
Immunobiology of cancer-associated fibroblasts in the context of radiotherapy.癌症相关成纤维细胞在放射治疗中的免疫生物学。
J Transl Med. 2021 Oct 18;19(1):437. doi: 10.1186/s12967-021-03112-w.
High-dose versus standard-dose twice-daily thoracic radiotherapy for patients with limited stage small-cell lung cancer: an open-label, randomised, phase 2 trial.大剂量与标准剂量每日 2 次胸部放疗治疗局限期小细胞肺癌患者:一项开放标签、随机、2 期试验。
Lancet Oncol. 2021 Mar;22(3):321-331. doi: 10.1016/S1470-2045(20)30742-7.
4
The elusive pursuit of progress in limited stage small-cell lung cancer.在局限期小细胞肺癌中对进展的难以捉摸的追求。
Lancet Oncol. 2021 Mar;22(3):290-291. doi: 10.1016/S1470-2045(21)00018-8.
5
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
6
Delivery of magnetic resonance-guided single-fraction stereotactic lung radiotherapy.磁共振引导的单次立体定向肺部放射治疗的实施
Phys Imaging Radiat Oncol. 2020 May 20;14:17-23. doi: 10.1016/j.phro.2020.05.002. eCollection 2020 Apr.
7
Survival in Patients With Brain Metastases: Summary Report on the Updated Diagnosis-Specific Graded Prognostic Assessment and Definition of the Eligibility Quotient.脑转移瘤患者的生存:诊断特异性分级预后评估更新的总结报告和资格系数的定义。
J Clin Oncol. 2020 Nov 10;38(32):3773-3784. doi: 10.1200/JCO.20.01255. Epub 2020 Sep 15.
8
ESMO Management and treatment adapted recommendations in the COVID-19 era: Lung cancer.ESMO 管理和治疗适应 COVID-19 时代的建议:肺癌。
ESMO Open. 2020 Jun;5(Suppl 3). doi: 10.1136/esmoopen-2020-000820.
9
Real world data of durvalumab consolidation after chemoradiotherapy in stage III non-small-cell lung cancer.III期非小细胞肺癌放化疗后度伐利尤单抗巩固治疗的真实世界数据。
Lung Cancer. 2020 Aug;146:23-29. doi: 10.1016/j.lungcan.2020.05.035. Epub 2020 May 31.
10
Evaluation of First-line Radiosurgery vs Whole-Brain Radiotherapy for Small Cell Lung Cancer Brain Metastases: The FIRE-SCLC Cohort Study.小细胞肺癌脑转移一线立体定向放疗与全脑放疗的评价:FIRE-SCLC 队列研究。
JAMA Oncol. 2020 Jul 1;6(7):1028-1037. doi: 10.1001/jamaoncol.2020.1271.